ATRI vs. KIDS, CSII, ATRC, LUNG, ICUI, QDEL, STAA, CERS, ANIK, and OSUR
Should you be buying Atrion stock or one of its competitors? The main competitors of Atrion include OrthoPediatrics (KIDS), Cardiovascular Systems (CSII), AtriCure (ATRC), Pulmonx (LUNG), ICU Medical (ICUI), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), Anika Therapeutics (ANIK), and OraSure Technologies (OSUR). These companies are all part of the "medical" sector.
Atrion (NASDAQ:ATRI) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.
Atrion has a net margin of 10.60% compared to OrthoPediatrics' net margin of -13.58%. Atrion's return on equity of 7.75% beat OrthoPediatrics' return on equity.
Atrion has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500.
66.2% of Atrion shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 22.8% of Atrion shares are held by insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
OrthoPediatrics has a consensus target price of $44.75, suggesting a potential upside of 37.27%. Given OrthoPediatrics' higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Atrion.
Atrion has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
OrthoPediatrics received 177 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.42% of users gave OrthoPediatrics an outperform vote while only 53.31% of users gave Atrion an outperform vote.
In the previous week, Atrion had 3 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for Atrion and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.94 beat Atrion's score of 0.76 indicating that OrthoPediatrics is being referred to more favorably in the news media.
Summary
OrthoPediatrics beats Atrion on 9 of the 17 factors compared between the two stocks.
Get Atrion News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
